Fabienne Beatrice Fischer

Fabienne Beatrice Fischer

Auto-generated profile, based on publicly available information

Fabienne Beatrice Fischer

Swiss Tropical and Public Health Institute

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
FFFabienne B. Fischer
Fabienne B. Fischer
CSClaudia Schmutz
Claudia Schmutz
VGValeria Gaia
Valeria Gaia
DMDaniel Maeusezahl
Daniel Maeusezahl
The risk of falling ill with Legionnaires’ disease (LD) is suggested to increase, but the global burden of disease is unknown due to a lack of appropriate diagnosis and surveillance systems. In Switzerland, the number of LD cases, captured by the National Notification System for Infectious Diseases, has more than doubled since 2008. This study aims to investigate this increase, contextualizing disease surveillance data with denominator data, which is not routinely available, i.e., the number of tests performed for Legionella spp. We collected the testing data for Legionella spp. of 14 Swiss diagnostic laboratories and calculated the positivity, defined as the proportion of the number of positive tests to the number of tests performed. The number of positive tests increased proportionally to the number of tests performed; hence, the positivity remained stable. However, the cause of the increase in test volume is unclear and has a large impact on the interpretation of the positivity curve. Further, the test outcome was found to be dependent on regional determinants, and the diagnostic method applied. The lack of understanding if and at which stage LD is considered in current case management of pneumonia patients limits the interpretation of observed heterogeneities in incidence or underestimation of LD in Switzerland. The absence of (or non-adherence to) existing guidelines and the heterogeneity in diagnostic testing hampers the comparison of data in the Swiss public health context. Therefore, diagnostic procedures should be harmonised across Switzerland and adherence to national LD management guidelines supported.

22 June 2023 in Environmental Research
Verified
Journal Article
Open access
FFFabienne B. Fischer
Fabienne B. Fischer
ASApolline Saucy
Apolline Saucy
DVDanielle Vienneau
Danielle Vienneau
JHJan Hattendorf
Jan Hattendorf
JFJulia Fanderl
Julia Fanderl
DMDaniel Maeusezahl
Daniel Maeusezahl
The number of reported cases of Legionnaires' disease (LD) has risen markedly in Switzerland (6.5/100,000 inhabitants in 2021) and abroad over the last decade. Legionella, the causative agent of LD, are ubiquitous in the environment. Therefore, environmental changes can affect the incidence of LD, for example by increasing bacterial concentrations in the environment or by facilitating transmission. The aim of this study is to understand the environmental determinants, in particular weather conditions, for the regional and seasonal distribution of LD in Switzerland. We conducted a series of analyses based on the Swiss LD notification data from 2017 to 2021. First, we used a descriptive and hotspot analysis to map LD cases and identify regional clusters. Second, we applied an ecological model to identify environmental determinants on case frequency at the district level. Third, we applied a case-crossover design using distributed lag non-linear models to identify short-term associations between seven weather variables and LD occurrence. Lastly, we performed a sensitivity analysis for the case-crossover design including NO2 levels available for the year 2019. Canton Ticino in southern Switzerland was identified as a hotspot in the cluster analysis, with a standardised notification rate of 14.3 cases/100,000 inhabitants (CI: 12.6, 16.0). The strongest association with LD frequency in the ecological model was found for large-scale factors such as weather and air pollution. The case-crossover study confirmed the strong association of elevated daily mean temperature (OR 2.83; CI: 1.70, 4.70) and mean daily vapour pressure (OR: 1.52, CI: 1.15, 2.01) 6-14 days before LD occurrence. Our analyses showed an influence of weather with a specific temporal pattern before the onset of LD, which may provide insights into the effect mechanism. The relationship between air pollution and LD and the interplay with weather should be further investigated.

1 May 2022 in International Journal of Hygiene and Environmental Health
Verified
Journal Article
Closed access
FFFabienne B. Fischer
Fabienne B. Fischer
DMDaniel Maeusezahl
Daniel Maeusezahl
MWMonica N. Wymann
Monica N. Wymann

11 March 2023 in Infection
Verified
Journal Article
Open access
PDF file
FFFabienne B. Fischer
Fabienne B. Fischer
MBMelina Bigler
Melina Bigler
DMDaniel Maeusezahl
Daniel Maeusezahl
JHJan Hattendorf
Jan Hattendorf
AEAdrian Egli
Adrian Egli
SBStefanie Bertschi
Stefanie Bertschi
Switzerland has one of the highest annual Legionnaires’ disease (LD) notification rates in Europe (7.8 cases/100,000 population in 2021). The main sources of infection and the cause for this high rate remain largely unknown. This hampers the implementation of targeted Legionella spp. control efforts. The SwissLEGIO national case–control and molecular source attribution study investigates risk factors and infection sources for community-acquired LD in Switzerland. Over the duration of one year, the study is recruiting 205 newly diagnosed LD patients through a network of 20 university and cantonal hospitals. Healthy controls matched for age, sex, and residence at district level are recruited from the general population. Risk factors for LD are assessed in questionnaire-based interviews. Clinical and environmental Legionella spp. isolates are compared using whole genome sequencing (WGS). Direct comparison of sero- and sequence types (ST), core genome multilocus sequencing types (cgMLST), and single nucleotide polymorphisms (SNPs) between clinical and environmental isolates are used to investigate the infection sources and the prevalence and virulence of different Legionella spp. strains detected across Switzerland. The SwissLEGIO study innovates in combining case–control and molecular typing approaches for source attribution on a national level outside an outbreak setting. The study provides a unique platform for national Legionellosis and Legionella research and is conducted in an inter- and transdisciplinary, co-production approach involving various national governmental and national research stakeholders.

16 June 2020 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
FFFabienne B. Fischer
Fabienne B. Fischer
ZMZulfira Mengliboeva
Zulfira Mengliboeva
GKGulzira Karimova
Gulzira Karimova
NANasrullo Abdujabarov
Nasrullo Abdujabarov
HPHelen Prytherch
Helen Prytherch
KWKaspar Wyss
Kaspar Wyss
Background: Within its reform efforts, the Government of Tajikistan is embracing the essential role of primary health care (PHC) in decreasing out of pocket (OOP) expenditures and increasing equity in access to health services. In the light of the increasing burden of disease relating to chronic conditions, we investigated OOP expenditures of patients with chronic conditions within a PHC setting; and if and how those expenditures are impacted by several interventions currently being implemented within Tajikistan. Methods: A cross-sectional survey among 1600 adult patients who had visited a PHC facility was conducted. The data obtained through interviews were descriptively analysed, and logistic regressions and gamma generalized linear models were performed. Results: The total OOP expenditures related to a patient’s last visit to the PHC facility were 17.2 USD for those with chronic conditions and 13.9 USD for those visiting due to an acute condition. Adjustment for potential confounders reduced the discrepancy from 3.3 USD to 0.5 USD. This convergence of costs was only observed in districts covered by the Basic Benefit Package (BBP), a governmental pilot project, aiming to standardise exemptions for payment and formal co-payments for health care services. Hence, we found the BBP to have a protective impact for patients with chronic conditions. However, considering the demographics of these patients (older in age, with greater dependency on pensions and social aid, and lower socio-economic status) in combination with the 40% higher utilisation rate of PHC and the high rate of onward referrals to specialists; it is clear that patients with chronic conditions continue to face substantial long-term costs and disadvantages. Conclusions: After accounting for confounders, patients with chronic and acute conditions faced similar costs related to a single visit to a PHC facility in districts covered by the BBP. However, greater efforts are required to ensure that citizens are well informed about their rights to health care, the BBP and the services that should be provided at no cost at the point of delivery. Moreover, the needs of patients with chronic conditions warrant a more integrative approach that takes long-term expenditures and services beyond the level of PHC into account.

29 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
FFFabienne Beatrice Fischer
Fabienne Beatrice Fischer
CSClaudia Schmutz
Claudia Schmutz
VGValeria Gaia
Valeria Gaia
DMDaniel Maeusezahl
Daniel Maeusezahl
Purpose: The risk of Legionnaires’ disease (LD) is suggested to increase, but the global burden of disease is unknown due to lack of appropriate diagnosis and surveillance systems. In Switzerland, the number of LD cases, captured by the National Notification System for Infectious Diseases, has more than doubled since 2008. The aim of this study is to evaluate disease surveillance data using denominator data i.e. the number of tests performed for Legionella . spp. Methods: We collected the testing data for Legionella spp. of 14 Swiss diagnostic laboratories and calculated the positivity rate, which is the rate of the number of positive tests to the number of tests performed. Results: The number of positive tests increased proportionally to the number of tests performed; hence the positivity remained stable. However, the cause of the increase in test volume is unclear and has a large impact on the interpretation of the positivity curve. Further, the test outcome was found to be dependent on regional determinants and the diagnostic method applied. Conclusion: In concert with the lack of understanding if and at which stage LD is considered in current case management of pneumonia patients, it is difficult to interpret heterogeneities in incidence or underestimation in Switzerland.